LOGO
LOGO

Orthofix Medical's Net Sales To Grow At CAGR Of 6% To 7% From 2025 Through 2027

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Shares of Orthofix Medical Inc. (OFIX), a medical technology company, have gained nearly 12% over the past three months and trade around $18.

This global spine and orthopedics company has a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, and specialized orthopedic solutions, among others. Its products are distributed in more than 60 countries worldwide.

For the full year of 2024, the company expects net sales to range between $795 million and $800 million, representing growth of approximately 6.6% to 7.2% compared to the net sales of $746.6 million generated in the full year of 2023.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19